302 related articles for article (PubMed ID: 27520989)
1. Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.
Mangiacapra F; Colaiori I; Ricottini E; Balducci F; Creta A; Demartini C; Minotti G; Di Sciascio G
Clin Res Cardiol; 2017 Jan; 106(1):69-75. PubMed ID: 27520989
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.
Nerla R; Di Franco A; Milo M; Pitocco D; Zaccardi F; Tarzia P; Sarullo FM; Villano A; Russo G; Stazi A; Ghirlanda G; Lanza GA; Crea F
Heart; 2012 Dec; 98(24):1812-6. PubMed ID: 23086971
[TBL] [Abstract][Full Text] [Related]
3. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease.
Hohneck AL; Fries P; Ströder J; Schneider G; Wagenpfeil S; Schirmer SH; Böhm M; Laufs U; Custodis F
J Hypertens; 2019 May; 37(5):1023-1031. PubMed ID: 30672832
[TBL] [Abstract][Full Text] [Related]
4. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
[TBL] [Abstract][Full Text] [Related]
5. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
6. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
[TBL] [Abstract][Full Text] [Related]
7. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
[TBL] [Abstract][Full Text] [Related]
8. The Assessment of short-term effect of L-Citrulline on endothelial function via FMD to NMD ratio in known CAD patients: A randomized, cross-over clinical trial (Clinical trial number: NCT02638727).
Safi M; Mahjoob MP; Nateghi S; Khaheshi I; Akbarzadeh MA; Naderian M
Rom J Intern Med; 2017 Mar; 55(1):23-27. PubMed ID: 27648629
[TBL] [Abstract][Full Text] [Related]
9. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
[TBL] [Abstract][Full Text] [Related]
10. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
Lekakis JP; Protogerou A; Papamichael C; Vamvakou G; Ikonomidis I; Fici F; Mavrikakis M
Cardiovasc Drugs Ther; 2005 Aug; 19(4):277-81. PubMed ID: 16187009
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
Jedlickova L; Merkovska L; Jackova L; Janicko M; Fedacko J; Novakova B; Chmelarova A; Majernik J; Pella D
Adv Ther; 2015 Oct; 32(10):962-70. PubMed ID: 26525390
[TBL] [Abstract][Full Text] [Related]
13. Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen.
Guaricci AI; Maffei E; Brunetti ND; Montrone D; Di Biase L; Tedeschi C; Gentile G; Macarini L; Midiri M; Cademartiri F; Di Biase M
Int J Cardiol; 2013 Sep; 168(1):362-8. PubMed ID: 23063141
[TBL] [Abstract][Full Text] [Related]
14. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study.
Akcakoyun M; Kargin R; Tanalp AC; Pala S; Ozveren O; Akcay M; Barutcu I; Kirma C
Coron Artery Dis; 2008 Aug; 19(5):337-43. PubMed ID: 18607171
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.
Skalidis EI; Hamilos MI; Chlouverakis G; Zacharis EA; Vardas PE
Atherosclerosis; 2011 Mar; 215(1):160-5. PubMed ID: 21183181
[TBL] [Abstract][Full Text] [Related]
17. Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
Lai J; Wu B; Sun J; Shang Y; Zhu J
Coron Artery Dis; 2013 Nov; 24(7):566-71. PubMed ID: 23994882
[TBL] [Abstract][Full Text] [Related]
18. Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography.
Guaricci AI; Schuijf JD; Cademartiri F; Brunetti ND; Montrone D; Maffei E; Tedeschi C; Ieva R; Di Biase L; Midiri M; Macarini L; Di Biase M
Int J Cardiol; 2012 Apr; 156(1):28-33. PubMed ID: 21095627
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
[TBL] [Abstract][Full Text] [Related]
20. Heart rate reduction with ivabradine in patients with acute decompensated systolic heart failure.
Sargento L; Satendra M; Longo S; Lousada N; dos Reis RP
Am J Cardiovasc Drugs; 2014 Jun; 14(3):229-35. PubMed ID: 24452599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
